Stay updated with breaking news from Tnxp. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
StockNews.com started coverage on shares of Tonix Pharmaceuticals (NASDAQ:TNXP – Free Report) in a research report report published on Friday. The firm issued a sell rating on the stock. Tonix Pharmaceuticals Stock Performance Tonix Pharmaceuticals stock opened at $0.40 on Friday. The company’s 50 day simple moving average is $0.48 and its 200-day simple moving […] ....
Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP – Get Free Report) was the target of a large growth in short interest in the month of December. As of December 15th, there was short interest totalling 1,500,000 shares, a growth of 308.7% from the November 30th total of 367,000 shares. Approximately 5.6% of the company’s stock are sold […] ....
By Chris Wack Tonix Pharmaceuticals shares were down 23% to 46 cents after the company signed securities purchase agreements with certain healthcare-focused. ....
By Chris Wack Tonix Pharmaceuticals said a Phase 3 study evaluating TNX-102 SL cyclobenzaprine HCl sublingual tablets met its pre-specified primary endpoint. ....
StockNews.com initiated coverage on shares of Tonix Pharmaceuticals (NASDAQ:TNXP – Free Report) in a report issued on Wednesday morning. The brokerage issued a hold rating on the stock. Tonix Pharmaceuticals Price Performance NASDAQ:TNXP opened at $0.57 on Wednesday. The firm has a 50 day simple moving average of $0.51 and a 200-day simple moving average […] ....